The global healthcare business collaboration tools market size was worth around USD 32.53 billion in 2024 and is expected to hit around USD 266.99 billion by 2034, growing at a CAGR of 23.43% from 2025 to 2034. The growth in the healthcare business collaboration tools market is because of factors such as increased demand for remote business services and healthcare services, increased use of digital technologies, and the demand for patient care management.
The global human chorionic gonadotropin market size was calculated at USD 2.15 billion in 2024 and is predicted to reach around USD 2.94 billion by 2034, expanding at a CAGR of 3.20% from 2025 to 2034. The human chorionic gonadotropin market is driven by the rising prevalence of infertility and increased demand for assisted reproductive technologies (ART) such as in-vitro fertilization (IVF).
The global cannula market size was calculated at USD 189.94 million in 2024 and is predicted to reach around USD 396.60 million by 2034, expanding at a CAGR of 7.64% from 2025 to 2034. The cannula market is driven by the increasing prevalence of minimally invasive surgeries.
The global surgical snare market size accounted for USD 2.27 billion in 2024 and is expected to exceed around USD 3.34 billion by 2034, growing at a CAGR of 3.96% from 2024 to 2034. The surgical snare market is driven by the increasing incidence of gastrointestinal (GI) conditions that necessitate minimally invasive operations like polypectomy and tumor removal, such as colorectal cancer and polyps.
The global post-traumatic stress disorder treatment market size is calculated at USD 2.28 billion in 2024 and is predicted to reach around USD 3.42 billion by 2034, expanding at a CAGR of 4.14% from 2024 to 2034. The post-traumatic stress disorder treatment market is driven by the growing understanding and acceptance of mental health issues.
The global spinal imaging market size is worth around USD 2.09 billion in 2024 and is anticipated to reach around USD 3.49 billion by 2034, growing at a CAGR of 5.23% from 2024 to 2034. The spinal imaging market is driven by the growing need for sophisticated diagnostic instruments like MRIs, CT scans, and X-rays to enable precise diagnosis and treatment planning due to the rising incidence of spinal illnesses like degenerative disc disease, spinal stenosis, and ruptured discs.
The global ureteral stents market size accounted for USD 575.54 million in 2024 and is expected to exceed around USD 1,128.19 million by 2034, growing at a CAGR of 6.96% from 2024 to 2034. A growing incidence of UTSDs, including kidney stones and obstructions, a growing geriatric population, technological innovations, and awareness amongst patients add to the ureteral stents market growth rate.
The global oral vaccine market size accounted for USD 3.87 billion in 2024 and is expected to exceed around USD 9.62 billion by 2034, growing at a CAGR of 9.54% from 2024 to 2034. The rising demand for oral vaccine market is attributable to the need for safer, easier-to-administrate, and more affordable vaccines than injectable vaccines.
The global fusion biopsy market size is calculated at USD 738.94 million in 2024 and is anticipated to reach around USD 1,690.87 million by 2034, expanding at a CAGR of 8.63% from 2024 to 2034. The increasing incidence of prostate cancer worldwide is the key factor driving the fusion biopsy market growth. Advancements in molecular profiling, coupled with the development of technology, can fuel market growth further.
The global vaccine adjuvants market size accounted for USD 1.73 billion in 2024 and is expected to exceed around USD 2.18 billion by 2034, growing at a CAGR of 2.33% from 2024 to 2034. The increasing adoption of the vaccine adjuvants market is as it is an essential component of vaccines in enhancing both immune response and efficacy.
The global lipid nanoparticles market size is worth around USD 1,002.63 million in 2024 and is anticipated to reach around USD 3,694.21 million by 2034, growing at a CAGR of 13.93% from 2024 to 2034. The lipid nanoparticles market is driven by the developments in mRNA therapies as well as the rise in chronic illnesses like cancer and heart disease.
The global medical imaging workstations market size is calculated at USD 9.40 billion in 2024 and is predicted to reach around USD 16.73 billion by 2034, expanding at a CAGR of 5.94% from 2024 to 2034. The medical imaging workstations market is rapidly growing because of the development in techniques related to imaging, the increasing rates of chronic diseases, the increased aging population, AI in imaging, telemedicine, upgrades in healthcare facilities, and the increased spending on healthcare demands for better diagnostic tools.
The global shingles vaccine market size is calculated at USD 4.94 billion in 2024 and is predicted to reach around USD 20.57 billion by 2034, expanding at a CAGR of 15.34% from 2024 to 2034. The increased risks of shingles in the elderly population are the key factors driving the growth of the market. Also, developments in healthcare policies in emerging markets coupled with the increasing shift towards innovative recombinant vaccines are expected to fuel the shingles vaccine market growth further.
The global portable ultrasound bladder scanner market size is worth around USD 281.84 million in 2024 and is anticipated to reach around USD 415.19 million by 2034, growing at a CAGR of 3.95% from 2024 to 2034. The increasing prevalence of urological diseases like urinary infections & incontinence, and bladder cancers are driving the portable ultrasound bladder scanner market. Additionally, increased demand for point-of-care diagnostics is contributing to the market expansion. With the rising adoption of cutting-edge medical devices in healthcare, the market is expected to boost in the forecast period.
The global automated microscopy market size accounted for USD 8.09 billion in 2024 and is expected to exceed around USD 15.08 billion by 2034, growing at a CAGR of 6.43% from 2024 to 2034. The automated microscopy market is driven by the growing need in the healthcare industry for precise and effective diagnostics.
The global analytical standards market size is calculated at USD 1.46 billion in 2024 and is predicted to reach around USD 2.77 billion by 2034, expanding at a CAGR of 6.60% from 2024 to 2034. Rising demand for testing in, environmental monitoring and pharmaceuticals is the key factor driving the growth of the market. Also, stringent regulations imposed by the government across the globe coupled with technological advancements can fuel market growth further.
The global dental tourism market size is worth around USD 13.35 billion in 2024 and is anticipated to reach around USD 97.93 billion by 2034, growing at a CAGR of 22.05% from 2024 to 2034. The demand for dental tourism is rising due to the expansion of the dental infrastructure in developing countries, which provides treatments at lower costs. This is attracting significant consumers from all around the world.
The global molecular biology enzymes, reagents, and kits market size is calculated at USD 25.24 billion in 2024 and is predicted to reach around USD 63.58 billion by 2034, expanding at a CAGR of 9.68% from 2024 to 2034. The molecular biology enzymes, reagents, and kits market is rising along with the increased genomic application, the growing need for molecular diagnostics, expectations for molecular personalized medicine, greater investment in research and development, and innovations in next-generation sequencing and automatization.
The global group life insurance market size is worth around USD 148.72 billion in 2024 and is expected to hit around USD 405.10 billion by 2034, growing at a notable CAGR of 10.54% from 2024 to 2034. The group life insurance market offers a common employee benefit to fulfill the needs of insured beneficiaries in case of emergency while being part of the organization.
The global dental diamond burs market size accounted for USD 2.67 billion in 2024 and is expected to exceed USD 3.71 billion by 2034, growing at a CAGR of 3.36% from 2024 to 2034. Growing demands for dental implants are driving the growth of the dental diamond burs market. Additionally, the rising adoption of cosmetic dentistry expands market success. A growing middle-class population and the availability of disposable income are expected to boost the market in the forecast period.
The global neuropathic pain market size is worth around USD 7.97 billion in 2024 and is expected to hit around USD 16.79 billion by 2034, growing at a CAGR of 7.73% from 2024 to 2034. The growing burden of neuropathic pain among patients suffering from chronic diseases is the key factor driving the neuropathic pain market growth. Also, an increase in demand for neuropathic treatment drugs coupled with the rise in government initiatives can fuel market growth further.
The U.S. pharmaceutical CDMO market size accounted for USD 40.52 billion in 2024 and is expected to exceed around USD 83.25 billion by 2034, growing at a CAGR of 7.50% from 2024 to 2034. The U.S. pharmaceutical CDMO market is driven by the growing need for biosimilars and biologics. Pharmaceutical businesses depend on CDMOs to supply the specialized knowledge, advanced manufacturing capabilities, and regulatory compliance needed for these complex medicines as they invest more and more in biologic therapies, such as vaccines, and monoclonal antibodies.
The global extraoral imaging market size accounted for USD 936.61 million in 2024 and is expected to exceed around USD 1,901.83 million by 2034, growing at a CAGR of 7.34% from 2024 to 2034. Advancements in imaging technologies are the key factor driving the growth of the market. Also, the rising incidence of dental disorders coupled with the increasing need for reliable imaging platforms can fuel the extraoral imaging market growth shortly.
The global microencapsulation market size is worth around USD 14.47 billion in 2024 and is expected to hit around USD 38.98 billion by 2034, growing at a CAGR of 10.42% from 2024 to 2034. The increased attention around microencapsulation technology is the key factor driving the growth of the microencapsulation market. Also, benefits related to microencapsulation coupled with the technology's application offer can fuel market growth further.
The global 3D printing in medical applications market size is worth around USD 4.13 billion in 2024 and is anticipated to reach around USD 19.74 billion by 2034, growing at a CAGR of 16.94% from 2024 to 2034. The 3D printing in medical applications market is driven by the growing need for individualized medical care, including prosthetics and implants made for each patient.
+1 804 441 9344
+61 485 981 310 +91 87933 22019
sales@precedenceresearch.com